Robotic Obstructive Sleep Apnea Surgery.

Robotic Obstructive Sleep Apnea Surgery. Adv Otorhinolaryngol. 2017;80:125-135 Authors: Toh ST, Hsu PP Abstract Since the first report of the use of the da Vinci robotic system (Intuitive Surgical, Sunnyvale, CA, USA) in transoral robotic tongue base reduction for obstructive sleep apnea (OSA) was published in 2010, this surgical tool and technique has been used worldwide for the resection of tongue base tissue in the multilevel surgical treatment of OSA. The combined knowledge of the published literature on its use has enlightened sleep surgeons worldwide on this new yet evolving surgical tool. Here we will discuss the use of the da Vinci robotic system in the treatment of OSA, the pertinent surgical anatomy for a safe surgical procedure, the primary and secondary outcomes to expect in the multilevel and primary use of this technology in treating the tongue base, the predictors for success or failure, and the complications associated with this technique. We will also compare this technology with other existing techniques for treating OSA and look to the future for other similar technologies in this application. PMID: 28738371 [PubMed - in process]
Source: Advances in Oto-Rhino-Laryngology - Category: ENT & OMF Tags: Adv Otorhinolaryngol Source Type: research

Related Links:

Authors: Jen R, Orr JE, Li Y, DeYoung P, Smales E, Malhotra A, Owens RL Abstract The co-existence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), termed the overlap syndrome (OVS), is associated with adverse outcomes that may be reversed with treatment. However, diagnosis is limited by the apparent need for in-laboratory polysomnography (PSG). WatchPAT is a portable diagnostic device that is validated for the diagnosis of OSA that might represent an attractive tool for the diagnosis of OVS.Subjects with established COPD were recruited from a general population. Subjects underwent ...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
Authors: Zhang J, Guo Y, Jia T, Guo H, Meng F, Xue S PMID: 31961111 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
Condition:   Sleep Apnea, Obstructive Interventions:   Drug: BAY2586116 (A1);   Drug: Placebo (A2);   Drug: BAY2586116 (B1);   Drug: BAY2586116 (B2);   Drug: BAY2586116 (B3) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: BaHammam AS, Almeneessier AS Abstract Previous studies have assessed the role of gender and menopause in Obstructive Sleep Apnea (OSA). It is well known that menopause is a major risk factor for OSA. However, analogous studies on obesity Hypoventilation Syndrome (OHS) are limited. Recent studies have suggested that OHS is more prevalent in postmenopausal women. Moreover, women with OHS seem to have excess comorbidities, including hypothyroidism, hypertension, pulmonary hypertension, and diabetes mellitus, compared to men. In the present perspective, we discuss recent data on the prevalence and comorbiditie...
Source: Open Respiratory Medicine Journal - Category: Respiratory Medicine Tags: Open Respir Med J Source Type: research
In conclusion, after excluding other possible causes of hypertension, we found OSA to be highly prevalent in hypertensive patients younger than 35  years old. Increasing age and high body mass index were predictors for OSA in young hypertensive patients.
Source: Internal and Emergency Medicine - Category: Emergency Medicine Source Type: research
The European Commission has approved Sunosi, a Jazz Pharmaceuticals sleep disorder treatment. Sunosi was approved, in 75- and 150-milligram doses, to improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea who did not respond to primary sleep apnea therapies such as continuous positive airway pressure. Jazz Pharmaceuticals, which is based in Dublin, Ireland, has major operations in Philadelphia where the company has nearly 200 employees.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Conditions:   Sleep Apnea;   Inflammation;   Atherosclerosis Intervention:   Other: myeloid PTP1B expression analysis Sponsor:   University Hospital, Angers Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionsIn this prospective study, OSA severity was independently associated with an increased risk of OI.
Source: Lung - Category: Respiratory Medicine Source Type: research
AbstractPurpose of ReviewThe prevalence of sleep-disordered breathing has greatly increased in the geriatric population.Recent FindingsThe pathophysiology of sleep-disordered breathing for this population varies from younger populations due to consequences of aging such as loss of neuromuscular tone, soft tissue hypertrophy, and tissue laxity. The importance of treating obstructive sleep apnea is obvious as it is linked to detrimental cardiovascular and cerebrovascular risks with additional effects on quality of life.SummaryTreatment of older patients is best met by evaluating their goals of treatment and meeting it with o...
Source: Current Otorhinolaryngology Reports - Category: ENT & OMF Source Type: research
Conditions:   Sleep Apnea;   Inflammation;   Atherosclerosis Intervention:   Other: myeloid PTP1B expression analysis Sponsor:   University Hospital, Angers Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anatomy | ENT & OMF | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine